Patent ID: 8778401

Claim:
An orally administrable pharmaceutical composition, said pharmaceutical composition comprising: a substantially water-insoluble pharmaceutical active ingredient selected from the group consisting of ibuprofen, fenofibrate, indomethacin, carbamazepine, and ursodeoxycholic acid in a stable amorphous form which is present at about 50% w/w to about 75% w/w; and a mesoporous composition having a plurality of nanopores and selected from the group consisting of MCM-41, MCM-48, SBA-15, MCF, MSU and CMK-3, wherein said substantially water-insoluble pharmaceutical active ingredient is spray-dried together with said mesoporous composition to entrap said pharmaceutical active ingredient within said nanopores, wherein there is no crystal growth detected after 12 months storage at 40° C. and 75% relative humidity of said stable amorphous form.